NCT06715618

Brief Summary

Rugby is a team contact sport that demands unparalleled physical engagement. This practice, which combines random running patterns with changes in speed and direction, also involves frequent contact situations with other players. These phases of the game account for 48% to 80% of total injuries. Injury prevention is an integral part of the physical therapist's expertise and plays a crucial role in reducing the occurrence of musculoskeletal injuries and mitigating their devastating consequences. The implementation of a risk prevention tool is particularly relevant for a population prone to injuries. However, the practicality of such a tool must be considered, as adherence to an injury prevention program depends on the "perceived usefulness, intensity, and time investment of the program". One tool appears to meet these criteria: the Functional Movement Screen™ (FMS™). This tool is designed to "evaluate an individual's functional movement patterns" and, according to its authors, can serve as "a crucial tool" for returning to sports after an injury or a period of inactivity. Given the high incidence of injuries in rugby players, calculating the injury incidence in this population and correlating it with FMS™ scores could provide valuable insights. For this prospective study, forty amateur rugby players from various clubs in Normandy competing at the Federal 3 level will be recruited using a recruitment letter and a call for volunteers. Each participant will perform two FMS™ (7 movements), at the beginning of the competitive season and at the end of the competitive season. The test will last 30 minutes per player. The initial interview will last 20 minutes. There will also be a follow-up of the players throughout the season to collect all injuries sustained by participants in the intervention. The main expected outcome is a significant correlation (p \< 0.05) between the FMS™ score and injury incidence. This correlation may then indicate a good predictive capacity of the FMS™, allowing it to be considered a predictive tool for injury risk. To evaluate the correlation between two variables (injury incidence sustained by the player and the FMS™ score), the Spearman correlation coefficient will be used. This coefficient, if its value approaches -1 or 1, will indicate a good correlation between the player's injury incidence and their FMS™ score. Conversely, if the coefficient approaches 0, the correlation will be considered poor. In a second phase, it is expected that a competitive season will directly affect the FMS™ score, highlighting the difficulty for an amateur player to maintain their physical capacities throughout an entire season.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2025

Completed
12 months until next milestone

Results Posted

Study results publicly available

May 4, 2026

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

November 28, 2024

Results QC Date

September 11, 2025

Last Update Submit

April 13, 2026

Conditions

Keywords

Amateur RugbyPreventionRiskInjuriesPlayers

Outcome Measures

Primary Outcomes (1)

  • The FMS™ Score

    The Functional Movement Screen™ (FMS™) is a tool designed to "evaluate an individual's functional movement patterns" and, according to its authors, can represent "a crucial tool" for returning to sport after an injury or a break from sports. It consists of an assessment of seven so-called fundamental movements, which require good neuromuscular and motor control, as well as balance and stability. These movements aim to place the evaluated subject in extreme positions to highlight significant imbalances throughout the body. This test consists of a score from 0 to 3 for each of the 7 movements, and a final score out of 21 points. The FMS reveals functional deficits by highlighting compensatory movements. The higher the score, the fewer compensatory movements.

    At the beginning of the season (baseline) for each player

Secondary Outcomes (1)

  • Injuries

    Through the season, up to 7 months per player

Study Arms (1)

FMS group

Each participant will perform two FMS™, one at the beginning of the competitive season. The test will take 30 minutes per player. The initial interview will last 20 minutes. Players will also be monitored throughout the season to collect all injuries sustained by the participants in the study.

Other: FMS test

Interventions

Each participant will perform two FMS™, one at the beginning of the competitive season. The test will take 30 minutes per player. The initial interview will last 20 minutes. Players will also be monitored throughout the season to collect all injuries sustained by the participants in the study.

FMS group

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The chosen study population consists of amateur rugby players from Normandy. Forty rugby players will be included in this study.

You may qualify if:

  • Players licensed with the French Rugby Federation (FFR): Their affiliation with the FFR requires a medical certificate confirming no contraindication to competitive sports practice.
  • Players aged at least 18 years old, legally adults.
  • Healthy players who have not sustained any musculoskeletal injuries or undergone surgical interventions in the past 6 months.
  • Players competing in "Fédérale 3."
  • Players from clubs based in Normandy.

You may not qualify if:

  • Minor players
  • Female players
  • Players injured during the first interview or the first FMS™
  • Players who are or have been professional athletes
  • Players with a history of frequent serious injuries that could pose a risk to their continued participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital La Musse

Saint-Sébastien-de-Morsent, 27180, France

Location

MeSH Terms

Conditions

Wounds and Injuries

Results Point of Contact

Title
Dr BAILLET Héloïse
Organization
Hôpital La Musse

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2024

First Posted

December 4, 2024

Study Start

October 3, 2024

Primary Completion

February 28, 2025

Study Completion

May 7, 2025

Last Updated

May 4, 2026

Results First Posted

May 4, 2026

Record last verified: 2026-04

Locations